Maciej Paszkowski

ORCID: 0000-0003-4271-9075 · 6 papers in corpus · active 2013-2026

Study types

  • article 3
  • other 2
  • rct 1

Condition tags

  • endometriosis 5
  • dysmenorrhea 2
  • chronic_pelvic_pain 2
  • dyspareunia 2
  • adenomyosis 1
other 2026
Linzagolix, with and without add-back therapy, in women with endometriosis-associated pain: results from EDELWEISS 6, a double-blind randomized extension and withdrawal study
Human reproduction open ·doi:10.1093/hropen/hoag030

STUDY QUESTION: Was the efficacy of linzagolix, observed at 6 months in women with endometriosis-associated pain, maintained when administered for an additional 6 months? SUMMARY ANSWER: Efficacy from this extension study complements the r…

article 2025
The Complex Aetiology of Chronic Pelvic Pain: Concomitance of Pelvic Venous Disorders and Adenomyosis.
·doi:10.22541/au.176553558.86973358/v1

Objective. To determine the prevalence of adenomyosis among patients with Pelvic Venous Disorders (PeVD) presenting with Chronic Pelvic Pain (CPP) and to assess the clinical response to ovarian vein embolization in cases of isolated PeVD ve…

other 2025
Two-year follow-up study (PRIMROSE 3) to assess bone mineral density in subjects with uterine fibroids completing the PRIMROSE 1 and PRIMROSE 2 linzagolix trials
Human reproduction open ·doi:10.1093/hropen/hoaf025

STUDY QUESTION: How important was the change in lumbar spine (L1-L4), femoral neck, and total hip bone mineral density (BMD) from post-treatment baseline values to 24 months after the end of treatment in PRIMROSE 1 and PRIMROSE 2 study part…

rct 2024
Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3)
Human Reproduction ·doi:10.1093/humrep/deae076

STUDY QUESTION: Does linzagolix administered orally once daily for up to 3 months at a dose of 75 mg alone or 200 mg in combination with add-back therapy (ABT) (1.0 mg estradiol; 0.5 mg norethindrone acetate, also known as norethisterone ac…

article 2015
Elastography Improves the Accuracy of Ultrasound in the Preoperative Assessment of abdominal wall endometriosis
Ultraschall in der Medizin (Stuttgart, Germany : 1980) ·doi:10.1055/s-0034-1398834

PURPOSE: To assess the role of elastography in preoperative ultrasound assessment of abdominal wall endometriosis (AWE) location. MATERIALS AND METHODS: 33 patients qualified for surgical excision of AWE were included in the study. Preopera…

article 2013
OC02.05: Elastography is superior to ultrasound in preoperative assessment of abdominal wall endometriosis
·doi:10.1002/uog.12588

Conclusions: 3D ultrasonography is useful only to increase the diagnostic accuracy of 2D in the diagnosis of other posterior localizations of deep endometriosis.